SWShu-Xia Wang

Shu-Xia Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shu-Xia Wang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Fei-Li Chen

    Department of Clinical Oncology, Division of lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P. R. China

    1 shared publication
  • Fen Zhang

    Department of Pathology, Guangdong Academy of Medical Sciences & Guangdong Provincial People's Hospital, Guangzhou, Guangdong, P. R. China

    1 shared publication
  • Han-Guo Guo

    Department of Clinical Oncology, Division of lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P. R. China

    1 shared publication
  • Hui Yuan

    PET Center, Department of Nuclear Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China

    1 shared publication
  • Jiachen Zou

    Department of Breast Cancer, Cancer Center, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China

    1 shared publication
  • Kun Wang

    Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital Southern Medical University Guangzhou Guangdong China

    1 shared publication

Latest Publications

  • Open Access

    18F-FDG PET/CT-based deep learning radiomics predicts 5-years disease-free survival after failure to achieve pathologic complete response to neoadjuvant chemotherapy in breast cancer

    by Xingxing Zheng, Yuhong Huang, Yingyi Lin, Teng Zhu, Jiachen Zou, Shuxia Wang, Kun Wang

    Background: This study aimed to assess whether a combined model incorporating radiomic and depth features extracted from PET/CT can predict disease-free survival (DFS) in patients who failed to achieve pathologic complete response (pCR) after neoadjuvant chemotherapy. Results: This study retrospectively included one hundred and five non-pCR patients. After a median follow-up of 71 months, 15 and 7 patients experienced recurrence and death, respectively. The primary tumor volume underwent feature extraction, yielding a total of 3644 radiomic features and 4096 depth features. The modeling procedure employed Cox regression for feature selection and utilized Cox proportional-hazards models to make predictions on DFS. Time-dependent receiver operating characteristic (ROC) curves and the area under the ROC curve (AUC) were utilized to evaluate and compare the predictive performance of different models. 2 clinical features (RCB, cT), 4 radiomic features, and 7 depth features were significant predictors of DFS and were included to develop models. The integrated model incorporating RCB, cT, and radiomic and depth features extracted from PET/CT images exhibited the highest accuracy for predicting 5-year DFS in the training (AUC 0.943) and the validation cohort (AUC 0.938). Conclusion: The integrated model combining radiomic and depth features extracted from PET/CT images can accurately predict 5-year DFS in non-pCR patients. It can help identify patients with a high risk of recurrence and strengthen adjuvant therapy to improve survival.


  • Primary cardiac lymphoma: the management and outcome of a single-centre cohort of 22 patients

    by Xiao-Juan Wei, Hui Yuan, Pek-Lan Khong, Fen Zhang, Peng-Jun Liao, Xin-Miao Jiang, Ling Huang, Han-Guo Guo, Fei-Li Chen, Si-Chu Liu, et al.

    The incidence of primary cardiac lymphoma (PCL) is increasing, but the optimal management approach remains unclear. We assessed the clinical characteristics of a single-centre cohort with the goal ...